Stockreport

Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma [Seeking Alpha]

CELGENE  (CELG) 
Last celgene earnings: 10/31 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celgene.com
PDF Citing the totality of the clinical data, Celgene (NASDAQ: CELG ) has amended the protocol in its Phase 2 clinical trial, KarMMa , assessing CAR T candidate b [Read more]